https://www.selleckchem.com/pr....oducts/zongertinib.h
14%, respectively; P0.001). Over a 5-year follow-up, Kaplan-Meyer analysis showed that adverse cardiac events (death or implantation of an LV assist device) were less frequently observed in the UDC than MDC group (6/28 vs. 15/28, respectively; P=0.027). Multivariate analysis revealed that UDC on MCG was the most significant predictor of CRT response (odds ratio 69.8; 95% confidence interval 13.14-669.32; P0.001). Preoperative non-invasive MCG may predict the CRT response and long-term outcome after CRT. Preoperative non-inva